Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
2(15%)
Results Posted
33%(3 trials)

Phase Distribution

Ph phase_2
1
8%
Ph phase_4
1
8%
Ph not_applicable
11
85%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution13 total trials
Phase 2Efficacy & side effects
1(7.7%)
Phase 4Post-market surveillance
1(7.7%)
N/ANon-phased studies
11(84.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

90.0%

9 of 10 finished

Non-Completion Rate

10.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

13

all time

Status Distribution
Active(2)
Completed(9)
Terminated(1)
Other(1)

Detailed Status

Completed9
Active, not recruiting1
unknown1
Recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (7.7%)
Phase 41 (7.7%)
N/A11 (84.6%)

Trials by Status

active_not_recruiting18%
unknown18%
completed969%
recruiting18%
withdrawn18%

Recent Activity

Clinical Trials (13)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
13